Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001239241-13-000001
Filing Date
2013-04-10
Accepted
2013-04-10 14:40:25
Documents
1
Period of Report
2012-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 4148
  Complete submission text file 0001239241-13-000001.txt   5732
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 21264957
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-31141 | Film No.: 13753467